@article{074207ceb1f845c7a3161756f60edab6,
title = "Comment: Avoiding detrimental effects of corticosteroids on JC virus T-cell responses-Primum non nocere",
author = "Koralnik, {Igor J.} and Clifford, {David B.}",
note = "Funding Information: I. Koralnik is funded by NIH grants R56 NS 041198, R01 NS 047029, R01 NS 074995, and K24 NS 060950 , and has received a research grant from Biogen Idec and the National Multiple Sclerosis Society. He served on scientific advisory boards for Hoffman La Roche, GlaxoSmithKline, and Merck Serono and received consulting fees from Bristol-Myers Squibb, Ono Pharmaceuticals, Merck Serono, Hoffman La Roche, GlaxoSmithKline, Perseid Therapeutics, Vertex Pharmaceutical, and Johnson & Johnson. D. Clifford serves on Data Safety Boards for Biogen, GSK, Millennium, Genzyme, Genentech, and Pfizer. He has been a consultant to Amgen, Brinker, Biddle, Reath (PML Consortium), Genentech, Genzyme, Bristol-Myers Squibb, Millennium, Biogen Idec, and Pfizer. He has received research support from Biogen Idec, NeurogesX, Tibotec, and Pfizer. Go to Neurology.org for full disclosures. ",
year = "2012",
month = dec,
day = "4",
doi = "10.1212/WNL.0b013e3182768a21",
language = "English",
volume = "79",
pages = "2263",
journal = "Neurology",
issn = "0028-3878",
number = "23",
}